BMC study: New Hepatitis C treatments cost-effective, but only for selected patients

(Boston University Medical Center) A study led by Boston Medical Center researchers demonstrates that while new therapies to treat Hepatitis C Virus are highly effective, they are cost-effective and provide the greatest value in specific groups of HCV-infected patients.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news